Testing for Hereditary Angioedema is Easy | CheckRare.com
In this video clip, Timothy Craig, DO of the Penn State Milton S. Hershey Medical Center describes some of the symptoms that may warrant testing for HAE.
Related Articles
Plans for a Phase 3 Clinical Trial Evaluating FLT201 in Patients With Gaucher Disease
Reena Sharma, MD, discusses plans for a phase 3 clinical trial evaluating FLT201 in patients with Gaucher disease.
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts
This Webinar examines what is PEGylation and the clinical uses of therapeutic proteins, and their applications in healthcare.
Neuroblastoma
Neuroblastoma is a rare childhood cancer characterized by a neuroendocrine tumor originating in neuroblasts or neural crest progenitor cells.
Effectiveness of Idursulfase in Patients With MPS II
Barbara Burton, MD, discusses a recent study examining the effectiveness of idursulfase in young patients with MPS II.
Arginine Vasopressin (AVP) Deficiency
AVP deficiency is a rare neuroendocrine disorder caused by impaired function of vasopressinergic neurons in the hypothalamus and posterior pituitary gland.
Complement-Mediated Kidney Disorders: A Case Series
Three case studies exploring complexities of diagnosing, treating, and managing patients with various complement-mediated kidney disorders.
Erdheim-Chester Disease
Erdheim-Chester disease is a rare condition affecting many parts of the body, it most commonly affects adults.
PAH Clinical Research Highlights: CHEST 2024
Jean Elwing discusses PAH research leading to better management of people with Pulmonary Arterial Hypertension
Results from the MajesTEC-2 and TRIMM-2 Clinical Trials for Patients With Multiple Myeloma
Anita D’Souza, MD, discusses results from the MajesTEC-2 and TRIMM-2 clinical trials for tec-DP in patients with multiple myeloma.
Improving Health Equity in Hereditary Angioedema (HAE): A Panel Discussion
Drs. Aleena Banerji, Timothy Craig, and Marc Riedl, provide an overview of the discrepancies and discuss improving health equity in HAE.